Basilea Pharmaceutica
BSLN.SW
#5986
Rank
A$1.62 B
Marketcap
A$130.92
Share price
0.14%
Change (1 day)
42.53%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: A$6.28

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is A$6.28. In 2025 the company made an earnings per share (EPS) of A$6.28 a decrease over its 2024 EPS that were of A$10.74.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025A$6.28-41.53%
2024A$10.74586.89%
2023A$1.56-6.28%
2022A$1.67-273.94%
2021A-$0.96-60.87%
2020A-$2.45-24.46%
2019A-$3.24-26.92%
2018A-$4.4459.83%
2017A-$2.78-63.06%
2016A-$7.52-19.26%
2015A-$9.3146.12%
2014A-$6.3710.07%
2013A-$5.79-36.76%
2012A-$9.15-5.42%
2011A-$9.68-153.36%
2010A$18.14-198.47%
2009A-$18.42-15.34%
2008A-$21.7616.7%
2007A-$18.6436.07%
2006A-$13.7079.07%
2005A-$7.65-46.79%
2004A-$14.389.83%
2003A-$13.09-38.94%
2002A-$21.44